These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37419245)

  • 21. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.
    Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE
    Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates.
    Al-Mahayri ZN; Khasawneh LQ; Alqasrawi MN; Altoum SM; Jamil G; Badawi S; Hamza D; George L; AlZaabi A; Ouda H; Al-Maskari F; AlKaabi J; Patrinos GP; Ali BR
    Hum Genomics; 2022 Sep; 16(1):42. PubMed ID: 36154845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.
    Fohner A; Muzquiz LI; Austin MA; Gaedigk A; Gordon A; Thornton T; Rieder MJ; Pershouse MA; Putnam EA; Howlett K; Beatty P; Thummel KE; Woodahl EL
    Pharmacogenet Genomics; 2013 Aug; 23(8):403-14. PubMed ID: 23778323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations.
    Bank PC; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Feb; 18(3):215-225. PubMed ID: 28112992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases.
    Jin M; Gock SB; Jannetto PJ; Jentzen JM; Wong SH
    J Anal Toxicol; 2005 Oct; 29(7):590-8. PubMed ID: 16419387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interrogating Pharmacogenetics Using Next-Generation Sequencing.
    Ji Y; Shaaban S
    J Appl Lab Med; 2024 Jan; 9(1):50-60. PubMed ID: 38167765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PharmVar GeneFocus: CYP3A5.
    Rodriguez-Antona C; Savieo JL; Lauschke VM; Sangkuhl K; Drögemöller BI; Wang D; van Schaik RHN; Gilep AA; Peter AP; Boone EC; Ramey BE; Klein TE; Whirl-Carrillo M; Pratt VM; Gaedigk A
    Clin Pharmacol Ther; 2022 Dec; 112(6):1159-1171. PubMed ID: 35202484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
    Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
    Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
    [No Abstract]   [Full Text] [Related]  

  • 29. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
    Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
    Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests.
    Lee SJ; Goldstein JA
    Pharmacogenomics; 2005 Jun; 6(4):357-71. PubMed ID: 16004554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral Therapy.
    Pasternak AL; Marcath LA; Li Y; Nguyen V; Gersch CL; Rae JM; Frame D; Scappaticci G; Kidwell KM; Hertz DL
    Transplant Cell Ther; 2022 Jan; 28(1):19.e1-19.e7. PubMed ID: 34583027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics research and clinical implementation in Brazil.
    Rodrigues-Soares F; Suarez-Kurtz G
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):538-549. PubMed ID: 30589990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
    Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
    Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review.
    Socco S; Wake DT; Lee JC; Dunnenberger HM
    Pharmacogenomics; 2022 Nov; 23(17):933-948. PubMed ID: 36326000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework.
    van der Wouden CH; Paasman E; Teichert M; Crone MR; Guchelaar HJ; Swen JJ
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32192029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
    Pritchard D; Patel JN; Stephens LE; McLeod HL
    Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of pharmacogenetic variation in nine biogeographic groups.
    Hernandez S; Hindorff LA; Morales J; Ramos EM; Manolio TA
    Clin Transl Sci; 2024 Sep; 17(9):e70017. PubMed ID: 39206687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications for pharmacogenomics in pharmacy practice: A scoping review.
    Hayashi M; Hamdy DA; Mahmoud SH
    Res Social Adm Pharm; 2022 Jul; 18(7):3094-3118. PubMed ID: 34474980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort.
    Kitzmiller JP; Luzum JA; Baldassarre D; Krauss RM; Medina MW
    Pharmacogenet Genomics; 2014 Oct; 24(10):486-91. PubMed ID: 25051018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.